We hypothesized that genetically predicted increased IL-6 and IL-6R activity would be associated with reduced gray matter volume and cortical thickness (CT) in areas highly relevant to neuropsychiatric disorders, including schizophrenia, autism spectrum disorder, and depression. Here, IL6 is linked to major depressive disorder.